To further evaluate whether EGFR, AKT, or ERK1/2 signalling is essential for Elafin-induced HCC metastasis, specific inhibitors of EGFR, AKT, or MEK/ERK were applied for the rescue experiments (Fig. S6A and B). Here, MAPK3 is linked to hepatocellular carcinoma.